<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C85FEE8F-4918-4146-B2FF-E4A55389BF80"><gtr:id>C85FEE8F-4918-4146-B2FF-E4A55389BF80</gtr:id><gtr:name>Oregon Health and Science University</gtr:name><gtr:address><gtr:line1>Oregon Health and Science University</gtr:line1><gtr:line4>Portland</gtr:line4><gtr:line5>OR 97201-30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C1ED9692-B6AE-4778-BF31-AE813E8E4415"><gtr:id>C1ED9692-B6AE-4778-BF31-AE813E8E4415</gtr:id><gtr:name>MRC Prion Unit</gtr:name><gtr:address><gtr:line1>MRC Prion Unit</gtr:line1><gtr:line2>Institute of Neurology</gtr:line2><gtr:line3>Queen Square</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1ED9692-B6AE-4778-BF31-AE813E8E4415"><gtr:id>C1ED9692-B6AE-4778-BF31-AE813E8E4415</gtr:id><gtr:name>MRC Prion Unit</gtr:name><gtr:address><gtr:line1>MRC Prion Unit</gtr:line1><gtr:line2>Institute of Neurology</gtr:line2><gtr:line3>Queen Square</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C85FEE8F-4918-4146-B2FF-E4A55389BF80"><gtr:id>C85FEE8F-4918-4146-B2FF-E4A55389BF80</gtr:id><gtr:name>Oregon Health and Science University</gtr:name><gtr:address><gtr:line1>Oregon Health and Science University</gtr:line1><gtr:line4>Portland</gtr:line4><gtr:line5>OR 97201-30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/898528A5-350A-4BCA-A93B-ACE4D8EF7358"><gtr:id>898528A5-350A-4BCA-A93B-ACE4D8EF7358</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:otherNames>Elisabeth</gtr:otherNames><gtr:surname>Lloyd</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U123160652"><gtr:id>461213A6-02EF-41AD-AE30-E6E5603EBFF1</gtr:id><gtr:title>Prion genetic modifiers in the mouse</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U123160652</gtr:grantReference><gtr:abstractText>Prion diseases in both humans and animals are characterised by a long, silent incubation periods before the disease emerges and this time interval varies greatly between individuals. Differences in our genetic makeup are a key factor in this variability. We already know that natural variation within one key gene, the prion protein gene, has a major influence on incubation time but it is now clear that a number of other genes are also important. If we can identify these genes and then find out what they do and how they vary between individuals we will have a much better understanding of the disease and why some individuals exposed to BSE have developed variant CJD and others have not. It may be that many others are infected but are still incubating the disease and the identification of these genes should allow much better predictions of any human epidemic. Such information should also cast light on the fundamental processes involved in these diseases and may provide new targets for drug therapies.||Identifying such genes in humans is extremely challenging and we have chosen to start our search in laboratory mice. Genetic studies of large mouse families have enabled us to narrow our search from the many thousands of genes down to a few hundred. We then look in detail at the DNA sequence of these candidate genes to find the small number of genes of importance. To show we have found the correct genes we will evaluate them in a cell based system to see if the gene influences cell susceptibility and prion replication. The ultimate proof that we have the right gene is provided by modifying the gene in mice and seeing if that actually results in the expected change in incubation period. Mice have largely the same genes as humans and so if we can find the key genes in mice, we can readily find their human counterparts. To test whether a candidate gene identified in our mouse studies is also important in human prion diseases we will search for variation in the equivalent human gene and use statistical analysis to test whether there is a link between genetic difference and susceptibility to human prion diseases such as variant CJD. Prion diseases share many features with other diseases of the ageing brain therefore the genes identified in these studies are expected to identify pathways and new therapeutic targets that are of wider relevance in neurodegeneration.</gtr:abstractText><gtr:technicalSummary>Prion diseases are characterised by a prolonged incubation period which is determined by many elements including genetic factors. Polymorphisms within the prion protein gene (Prnp) are a major genetic influence on incubation time and susceptibility however it is becoming increasingly evident that variation at other genetic loci may also make a significant contribution. The identification of key polymorphisms, genes and pathways will increase our understanding of the underlying principles of prion biology, provide novel targets for therapeutic intervention and help identify those individuals at greatest risk of developing prion disease.||Linkage analysis performed to date in various mouse crosses has mapped several genetic loci of interest and our on-going research is aimed at refining these localisations and identifying candidate genes. The use of a heterogeneous stock of mice for genetic mapping has successfully reduced the size of several target regions to 1-2Mb so that a candidate gene approach is now feasible. Genes are evaluated by searching for polymorphisms within the mRNA, intron-exon boundaries and regulatory regions and are tested in the cross to assess their potential contribution to the observed phenotypic variation. Additional analysis may also be done by quantitative gene expression studies between mouse strains in both the unaffected and affected state.||As part of a Unit wide effort, we will test candidate genes for prion disease-related functions using an in-vitro assay whereby the gene function is impaired by RNAi knockdown and the effect on cell susceptibility and prion propagation is determined (Scrapie Cell Assay).||Where a promising candidate gene has been identified, new mouse models are being generated to test in-vivo whether over-expression or knockout of the gene significantly modifies prion disease incubation time as predicted by our genetic analyses.||While mouse models are an invaluable tool, our ultimate aim is to identify the genes and their polymorphisms that also influence susceptibility to various human prion diseases. To this end, quantitative trait genes successfully identified by our mouse studies are being evaluated by haplotype or single polymorphism association studies in our collections of DNA from patients affected by prion disease. In addition, these studies principally aim to understand fundamental processes, and potentially identify new therapeutic targets, which may be of generic importance in neurodegeneration and protein misfolding diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2017-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>5808976</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Tc1 prion</gtr:description><gtr:id>2C484730-D95E-4A08-B45F-DD601A08873C</gtr:id><gtr:impact>Publication PMID 22869728</gtr:impact><gtr:outcomeId>5450f88bb69806.51189874-2</gtr:outcomeId><gtr:partnerContribution>Gift of Tc1 mice</gtr:partnerContribution><gtr:piContribution>Inoculation of mice with prions for measurement of incubation time and subsequent biochemistry and histology.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tc1 prion</gtr:description><gtr:id>26611F73-0B3D-4DA5-8E44-1783A54FA881</gtr:id><gtr:impact>Publication PMID 22869728</gtr:impact><gtr:outcomeId>5450f88bb69806.51189874-1</gtr:outcomeId><gtr:partnerContribution>Gift of Tc1 mice</gtr:partnerContribution><gtr:piContribution>Inoculation of mice with prions for measurement of incubation time and subsequent biochemistry and histology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oregon Health and Science University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Behavioral Neuroscience</gtr:department><gtr:description>Mapping quantitative trait loci in heterogenous mice</gtr:description><gtr:id>A5552DAA-2829-4A9F-AD28-8EEF77D7B161</gtr:id><gtr:impact>Identification of Hectd2, Cpne8 as candidate genes for prion disease incubation time in mice. Also used as evidence to exlude Sprn from a role in prion disease incubation time. PubMed ID: 19214206, 19795140, 19513788</gtr:impact><gtr:outcomeId>CC0BCE943B1-1</gtr:outcomeId><gtr:partnerContribution>Donated Heterogeous stock mice breeding pairs</gtr:partnerContribution><gtr:piContribution>Measured prion disease incubation time and genotyped mice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Proteomics</gtr:description><gtr:id>B2F254DE-4487-4440-8318-D03D5FD79688</gtr:id><gtr:impact>Publication DOI 10.1039/C3SC50826A</gtr:impact><gtr:outcomeId>5450f9a06b8400.27943516-1</gtr:outcomeId><gtr:partnerContribution>Identified protein candidates by proteomic analysis</gtr:partnerContribution><gtr:piContribution>Genetic analysis of inbred mouse candidate genes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Transgenic mouse overexpressing the mouse gene Hspa13 (Stch)</gtr:description><gtr:id>98E19BB4-D688-4B0E-8168-CF00E4D0320D</gtr:id><gtr:impact>Publication PMID 22869728</gtr:impact><gtr:outcomeId>Hm9MbJTyMFk</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tg222 (Stch Transgenic)</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>http://europepmc.org/abstract/MED/22869728</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>PK1 cells stably knocked down (using siRNA technology) or overexpressing selected genes relevant to prion disease. Cell lines particularly developed for use with the scrapie cell assay method of prion propagation assay as a means of triaging candidate genes.</gtr:description><gtr:id>53A7542F-5D02-4506-8FC4-DE7C569D58D1</gtr:id><gtr:impact>Reduction in need to use mice in screening of candidate modifier genes for prion disease. Published PMID 24833721</gtr:impact><gtr:outcomeId>5450fd33d677e5.34163043</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Stable Knockdown or overexpressing PK1 cells</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C5ED7A14-685A-4713-B33E-13DCC08C2E8C</gtr:id><gtr:title>Microglial Cx3cr1 knockout reduces prion disease incubation time in mice.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e86547207e717145b8a8421a11f93161"><gtr:id>e86547207e717145b8a8421a11f93161</gtr:id><gtr:otherNames>Grizenkova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn><gtr:outcomeId>5450f5d39de5a0.34200102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99A0F470-A892-4478-90F3-0F6BDAC5EC9A</gtr:id><gtr:title>Genetics of prion diseases.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>pm_14802_22_23518043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>424F137B-9B70-4781-94F3-D7F89496F553</gtr:id><gtr:title>HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>TPoTU5caLXw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BFBC787-3498-4012-A0E8-4F12C29BFC4C</gtr:id><gtr:title>A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>beXciECjyfm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFC5703B-BC28-4716-9ED0-B2CE581D5F69</gtr:id><gtr:title>The Retinoic Acid Receptor Beta (Rarb) Region of Mmu14 Is Associated with Prion Disease Incubation Time in Mouse</gtr:title><gtr:parentPublicationTitle>PLoS ONE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e86547207e717145b8a8421a11f93161"><gtr:id>e86547207e717145b8a8421a11f93161</gtr:id><gtr:otherNames>Grizenkova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>KMFCykNYr35</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>980C3B2F-92D0-41A4-B125-CD53F6C0CE50</gtr:id><gtr:title>Rare structural genetic variation in human prion diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44154794c63211aac745864409e98d53"><gtr:id>44154794c63211aac745864409e98d53</gtr:id><gtr:otherNames>Lukic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56c3176f208c15.82339570</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C974AABA-E506-4473-9F35-069B63ACB0F5</gtr:id><gtr:title>HECTD2 is associated with susceptibility to mouse and human prion disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>j13dji5TQ6q</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E0C0B9B-AB68-4865-AC6B-62EAAF72CDC1</gtr:id><gtr:title>Glycomimetic affinity-enrichment proteomics identifies partners for a clinically-utilized iminosugar</gtr:title><gtr:parentPublicationTitle>Chemical Science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1ec47a56725f3c97c768d0b39989fd0"><gtr:id>f1ec47a56725f3c97c768d0b39989fd0</gtr:id><gtr:otherNames>Cruz I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>doi_14802_c3sc50826a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF537B35-023F-46F1-B53C-C55EA4CCFD62</gtr:id><gtr:title>In vitro screen of prion disease susceptibility genes using the scrapie cell assay.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e14ad7dc46751cc03b82cf6e81f69dc"><gtr:id>9e14ad7dc46751cc03b82cf6e81f69dc</gtr:id><gtr:otherNames>Brown CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5450f5f231c1c8.20886267</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6638EE44-C4B2-48C5-B017-80AA2A93392A</gtr:id><gtr:title>Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2b42af3d965ec21e991e161c0a0cf29"><gtr:id>b2b42af3d965ec21e991e161c0a0cf29</gtr:id><gtr:otherNames>O'Shea M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn><gtr:outcomeId>F7FF975A491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B681276E-6342-4BEE-819A-ED8641308094</gtr:id><gtr:title>Overexpression of the Hspa13 (Stch) gene reduces prion disease incubation time in mice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e86547207e717145b8a8421a11f93161"><gtr:id>e86547207e717145b8a8421a11f93161</gtr:id><gtr:otherNames>Grizenkova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_14802_22_22869728</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A78458FF-1C2F-49FE-ADDF-FCD9DDB563E6</gtr:id><gtr:title>Sex effects in mouse prion disease incubation time.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ae69f09236d5a7d55a0d981da8f5d0e"><gtr:id>0ae69f09236d5a7d55a0d981da8f5d0e</gtr:id><gtr:otherNames>Akhtar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14802_22_22174884</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C9226423-3FCD-412D-AA44-1AA9FF52AF33</gtr:id><gtr:title>Sod1 deficiency reduces incubation time in mouse models of prion disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ae69f09236d5a7d55a0d981da8f5d0e"><gtr:id>0ae69f09236d5a7d55a0d981da8f5d0e</gtr:id><gtr:otherNames>Akhtar S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14802_22_23349894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBB5BD70-B8B9-4AF2-AE15-8544E7A6CE2F</gtr:id><gtr:title>Genetics of prion disease.</gtr:title><gtr:parentPublicationTitle>Topics in current chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f77f35fd10f11cc2beec3df854647449"><gtr:id>f77f35fd10f11cc2beec3df854647449</gtr:id><gtr:otherNames>Lloyd S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-1022</gtr:issn><gtr:outcomeId>pm_14802_22_21528440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EBCD584-315A-4895-83F0-9350D09B99E9</gtr:id><gtr:title>Shadoo (Sprn) and prion disease incubation time in mice.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aed3a8442858c25b62567496b0f208ac"><gtr:id>aed3a8442858c25b62567496b0f208ac</gtr:id><gtr:otherNames>Lloyd SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>AFC48C91EB0</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U123160652</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>